Related references
Note: Only part of the references are listed.
Article
Infectious Diseases
Fatih Colkesen et al.
Summary: The severity of COVID-19 is associated with selective IgA deficiency (SIgAD). Patients with SIgAD have a higher risk of severe COVID-19, and serum IgA levels are correlated with disease severity.
JAPANESE JOURNAL OF INFECTIOUS DISEASES
(2022)
Article
Immunology
Peter F. Wright et al.
Summary: Respiratory/mucosal and serum/systemic antibody responses to SARS-CoV-2 infection are distinct host defense mechanisms influenced by age, severity of illness, and immunoglobulin class. Stimulation of respiratory immunity is crucial for SARS-CoV-2 vaccines aiming to limit transmission.
JOURNAL OF INFECTIOUS DISEASES
(2022)
Article
Infectious Diseases
Anika Singanayagam et al.
Summary: Vaccination reduces the risk of delta variant infection and accelerates viral clearance. However, fully vaccinated individuals with breakthrough infections may still have similar peak viral loads as unvaccinated cases and can efficiently transmit the infection.
LANCET INFECTIOUS DISEASES
(2022)
Article
Medicine, General & Internal
David W. Eyre et al.
Summary: In this study, it was found that vaccination reduces the transmission risk of the Delta variant, but the protection of the vaccine decreases over time. The effectiveness of the vaccine is higher against the Alpha variant compared to the Delta variant.
NEW ENGLAND JOURNAL OF MEDICINE
(2022)
Article
Critical Care Medicine
Marc Chadeau-Hyam et al.
Summary: Despite high levels of vaccination among adults, England has experienced a third wave of the COVID-19 epidemic since the end of May 2021, coinciding with the rapid spread of the delta variant. In September, infections were increasing exponentially in children aged 5-17 years, at a time when vaccination rates were low in this age group.
LANCET RESPIRATORY MEDICINE
(2022)
Article
Biochemistry & Molecular Biology
Zeli Zhang et al.
Summary: Multiple COVID-19 vaccines have successfully protected against symptomatic cases and deaths. Comparisons of T cell, B cell, and antibody responses to different vaccines can provide insights into protective immunity against COVID-19, particularly immune memory. mRNA vaccines and Ad26.COV2.S induced strong T cell responses, while mRNA vaccines showed substantial declines in antibodies.
Article
Immunology
Salma Sheikh-Mohamed et al.
Summary: Although SARS-CoV-2 mainly infects the upper respiratory tract, little is known about the antibodies generated in the oral cavity in response to COVID-19 vaccination. This study found that most participants had detectable antibodies in their saliva after the first dose of mRNA vaccine. The second dose boosted the IgG response but had little effect on the IgA response. Participants with lower levels of vaccine-induced IgA were more likely to experience breakthrough infections.
MUCOSAL IMMUNOLOGY
(2022)
Article
Critical Care Medicine
Fengcai Zhu et al.
Summary: This study evaluated the safety and immunogenicity of a live-attenuated influenza virus vector-based SARS-CoV-2 vaccine administered through intranasal spray in healthy adults. The vaccine was well tolerated and elicited a certain level of immune response in adults. Further research is needed to validate intranasal vaccines as a potential supplement to current intramuscular vaccine options.
LANCET RESPIRATORY MEDICINE
(2022)
Article
Immunology
Jinyi Tang et al.
Summary: SARS-CoV-2 mRNA vaccination induces strong immune responses in the circulation, but its effectiveness in the respiratory tract, especially against variants of concern like Omicron, is still uncertain. This study found lower neutralizing antibody responses in the respiratory tract of vaccinated individuals compared to COVID-19 convalescents, despite robust antibody responses in the blood. Vaccination also induced circulating B and T cell immunity, but these responses were absent in the respiratory tract. Mouse immunization experiments showed that systemic mRNA vaccination alone resulted in weak respiratory mucosal neutralizing antibody responses, but combining it with mucosal adenovirus-S immunization produced strong neutralizing antibody responses against both the ancestral virus and the Omicron variant. Overall, this study suggests that current COVID-19 vaccines are highly effective against severe disease, but provide limited protection against breakthrough infections, particularly by the Omicron sublineage.
SCIENCE IMMUNOLOGY
(2022)
Article
Public, Environmental & Occupational Health
Hiam Chemaitelly et al.
Summary: The duration of immunity provided by natural infection of SARS-CoV-2 diminishes over time and may disappear within a few years, with viral immune evasion accelerating this process. However, protection against severe reinfection remains very strong, regardless of the variant, for over 14 months after the primary infection.
JOURNAL OF TRAVEL MEDICINE
(2022)
Article
Medicine, General & Internal
Alasdair P S Munro et al.
Article
Multidisciplinary Sciences
Carolina Lucas et al.
Summary: This study found that individuals previously infected with the virus had higher antibody titres post-vaccination compared to those who were uninfected, but both groups reached comparable levels of neutralization responses to the ancestral strain after the second vaccine dose. Comprehensive analysis of 16 locally circulating SARS-CoV-2 variants revealed varying degrees of reduction in neutralization capacity associated with specific mutations in the spike gene, suggesting vaccine boosters as a relevant future strategy to counteract the impact of emerging variants on antibody neutralizing activity.
Article
Microbiology
Chris Davis et al.
Summary: Vaccines have proven to be effective in controlling hospitalisation and deaths associated with SARS-CoV-2 infection, but the emergence of viral variants with novel antigenic profiles raises concerns. Serum from vaccine recipients showed reduced neutralisation against SARS-CoV-2 variants like B.1.617.1, B.1.617.2, and B.1.351. The BNT162b2 vaccine induced higher neutralising antibody titres compared to the ChAdOx1 vaccine, but both vaccines showed decreased efficacy against certain variants.
Article
Critical Care Medicine
Rachael A. Evans et al.
Summary: The study aimed to understand the impact of COVID-19-related hospitalization on health and employment, identify factors associated with recovery, and describe recovery phenotypes. Findings revealed that some patients did not fully recover six months after discharge, with factors such as female sex, middle age, comorbidities, and severe illness contributing to difficulties in recovery. The study also identified four different recovery phenotypes.
LANCET RESPIRATORY MEDICINE
(2021)
Article
Immunology
Nikaia Smith et al.
Summary: This study conducted a paired analysis of nasopharyngeal and systemic immune responses in COVID-19 patients, revealing distinct compartmentalization of immunity and shifts in the microbiome.
Article
Medicine, General & Internal
Philip R. Krause et al.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Multidisciplinary Sciences
Janeri Froberg et al.
Summary: Limited research has been done on the role of mucosal immune response to SARS-CoV-2 infection. This study finds that mucosal antibody responses are associated with decreased viral load and faster resolution of systemic symptoms in COVID-19 patients. Receptor binding domain and spike protein-specific mucosal antibodies remained elevated up to nine months after symptom onset.
NATURE COMMUNICATIONS
(2021)
Article
Microbiology
Jia Wei et al.
Summary: A longitudinal study on 45,965 adults in the UK revealed that older individuals, especially those aged >60 years, had lower antibody levels after a single dose of ChAdOx1 or BNT162b2 COVID-19 vaccines. Prioritizing vaccine allocation for those not previously infected and older individuals for the second dose is recommended based on the findings. Further data is needed to fully understand the relationship between quantitative antibody responses and vaccine-mediated protection.
NATURE MICROBIOLOGY
(2021)
Article
Medicine, General & Internal
Annemarie B. Docherty et al.
BMJ-BRITISH MEDICAL JOURNAL
(2020)
Article
Infectious Diseases
J. C. Marshall et al.
LANCET INFECTIOUS DISEASES
(2020)
Article
Virology
Marina Johnson et al.
JOURNAL OF CLINICAL VIROLOGY
(2020)
Article
Nutrition & Dietetics
Yuji Naito et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
(2020)
Review
Health Care Sciences & Services
Beibei Guo et al.
STATISTICAL METHODS IN MEDICAL RESEARCH
(2017)
Article
Multidisciplinary Sciences
Tadaki Suzuki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2015)
